Home
Growth Equity Opportunities 18 VGE reported a 6.2% stake in X4 Pharmaceuticals XFOR · 5,057,610 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 6.2%
- Last report
- 9.99% · filed 25/08/15
- Shares held
- 5,057,610 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 25/10/27
- Filed
- 25/10/29
6.2% stake · −3.8pp from the last report
- Stake
- 6.2%
- Last report
- 9.99%
- Since last report
- −3.8pp
X4 Pharmaceuticals trades, last 26 weeks
What else happened in X4 Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/09/27~25/11/26Growth Equity Opportunities 18 VGE's other 5% stake reports
- Growth Equity Opportunities 18 VGE
5% stakeCelcuity
5% stakeCelcuity
CELC
4.9% stake
2,285,561 sh
4.9% stake
Filed 03/09
- Growth Equity Opportunities 18 VGE
5% stakeGossamer Bio
5% stakeGossamer Bio
GOSS
1.7% stake
4,065,134 sh
1.7% stake
Filed 02/24
- Growth Equity Opportunities 18 VGE
5% stakeCelcuity
5% stakeCelcuity
CELC
6.3% stake
2,910,561 sh
6.3% stake
Filed 01/16
- Growth Equity Opportunities 18 VGE
5% stakeCelcuity
5% stakeCelcuity
CELC
8.1% stake
3,535,561 sh
8.1% stake
Filed 25/08/18
- Growth Equity Opportunities 18 VGE
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
9.99% stake
2,243,658 sh
9.99% stake
Filed 25/08/15
